Belantamab mafodotin with bortezomib and dexamethasone for previously treated multiple myeloma

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee B.

Committee members are asked to declare any interests in the technologies being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chair

Charles Crawley
Chair, technology appraisal committee B

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Ross Wilkinson and Lauren Elston
Technical leads

Alexandra Sampson and Nigel Gumbleton
Technical advisers

Thomas Feist and Vonda Murray
Project managers

Richard Diaz
Associate director

ISBN: 978-1-4731-9446-5